TMO Initiated Coverage by CLSA -- Outperform Rating with Price Target of $748

gurufocus.com · 2026-09-03

Thermo Fisher Scientific (TMO) Analyst Rating Update On October 27, 2023, Thermo Fisher Scientific (TMO) received an "Outperform" rating from CLSA analyst Mi

TickrTrends take: CLSA's initiation of coverage with an Outperform rating and a price target of $748 provides a new analyst perspective on TMO, a Healthcare sector company currently assessed as Fairly valued by TickrTrends. For valuation-focused investors, the gap between CLSA's price target and the current market price will be an important metric to monitor, as it may indicate whether the market is repricing the company or whether analyst expectations diverge from broader valuation consensus. The timing and conviction of this coverage initiation could influence how the Fairly valued assessment evolves if the market begins to reflect CLSA's more positive outlook.

Read the full story at gurufocus.com →